Program Director in the Neurodegeneration Cluster, NIH/NINDSBiography
Dr. Margaret Sutherland joined the NINDS in 2007 and serves as a Program Director in the Neurodegeneration Cluster at NINDS. She currently oversees research grant portfolios and programs in: i) Huntington's Disease; ii) Frontotemporal Dementia and iii) basic and clinical studies supporting the genetics, protein flux, mitochondrial dynamics, synuclein biology and stem cell based-research associated with Parkinson's Disease. Dr. Sutherland manages the CINAPS contract which is designed to support pre-clinical validation of therapeutic targets for Parkinson's Disease. She also oversees consortia focused on the development and utilization of induced pluripotent stem cell resources for advancement of basic and translational research in neurodegenerative diseases. Dr. Sutherland received her undergraduate degree in Microbiology and Immunology from the University of Western Ontario and her Ph.D. in Molecular Neuroscience from the Laboratory of Molecular Biology (LMB), Cambridge UK. She completed her postdoctoral training with Dr. Jeffrey Noebels, in the Department of Neurology, at the Baylor College of Medicine where she developed transgenic mouse models of absence seizures (overexpression of voltage-gated K+ channels) and enhanced astroglial glutamate transport. Prior to joining the NINDS, Dr. Sutherland was a faculty member in the Center for Neuroscience Research at the Children's National Medical Center (CNMC), where she directed NIH-funded research programs on excitotoxicity mechanisms in neurodegeneration and epilepsy and served as director of the CNMC Transgenic Core facility.